• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX
Click for more information
11.2% $4.38

MAYNE PHARMA GROUP LIMITED - Corporate Spotlight

Market Cap $372.6M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

No Corporate Spotlight currently available.

(20min delay)
Last
$4.38 		Change
0.440(11.2%) 		Mkt cap ! $372.6M
Open High Low Value Volume
$4.40 $4.79 $4.18 $2.649M 590.1K

Buyers (Bids)

No. Vol. Price($)
1 1271 $4.35
 

Sellers (Offers)

Price($) Vol. No.
$4.44 1271 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
$4.38 		  Change
0.440 ( 11.0 %)
Open High Low Volume
$4.42 $4.79 $4.21 26856
Last updated 15.59pm 23/08/2024 ?
MYX (ASX) Chart

Top Stories

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
The Rising Tide: How institutional adoption is shaping the future of crypto This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.